JERUSALEM, Israel — Teva Pharmaceutical Industries Ltd. has launched metformin hydrochloride extended-release tablets, a medication for type 2 diabetes, in the United States. Teva said Monday that its metformin product, available in 500-mg and 1,000-mg dosages, is a generic version of Glumetza tablets from Valeant Pharmaceuticals International. Metformin hydrochlorideER tablets are indicated for use with
LAVAL, Quebec — Bausch + Lomb has rolled out PreserVision AREDS 2 Formula + Multivitamin, a two-in-one eye supplement aimed at making it simpler for consumers to get their nutrients. The Valeant Pharmaceuticals International subsidiary said Thursday that PreserVision AREDS 2 Formula + Multivitamin is the first leading brand to combine the National Eye Institute-recommended
NEW YORK — Stefano Pessina likes what he sees after Walgreens Boots Alliance (WBA) finished its first full year as a unified company. WBA’s executive vice chairman and chief executive officer told shareholders at its annual meeting here that the company expects its deal to acquire Rite Aid Corp. and its partnership with Valeant Pharmaceuticals
NEW YORK — Walgreens Boots Alliance’s deal to acquire Rite Aid and partnership with Valeant Pharmaceuticals will build on WBA’s strong start in its first full year as a unified company, executive vice chairman and CEO Stefano Pessina said here at the annual shareholders meeting. “I am happy to say that we are on track
In many significant ways, the chain drug store business looks very different at the start of 2016 than it did a year ago. Walgreens Boots Alliance, which emerged from a two-step merger process at the close of 2014, spent the past 12 months rationalizing operations in the United States and developing synergies with its retail
NEW YORK — After CVS Caremark and two other pharmacy benefit managers announced that they are terminating mail-order pharmacy Philidor Rx Services LLC from their networks, Valeant Pharmaceuticals Inc. said it would also sever ties with Philidor. Philidor has been accused of bolstering sales of products made by the Canadian-based drug manufacturer Valeant. Joining CVS
LAVAL, Quebec — Valeant Pharmaceuticals International Inc. plans to acquire Sprout Pharmaceuticals Inc., the maker of a just-approved drug for sexual desire disorder in women, for about $1 billion in cash. Valeant said Thursday that it expects to close the deal in the third quarter of this year, pending customary closing conditions and regulatory approval.
BRIDGEWATER, N.J. — Valeant Pharmaceuticals North America’s AcneFree brand has introduced AcneFree Drying Lotion, a fast-acting acne spot treatment for breakouts and occasional flare-ups. Valeant said Monday that the hypoallergenic AcneFree Drying Lotion features a quick-drying formula that gently and instantly hides whiteheads and pimples. The product also is an overnight treatment. Users apply it
LAVAL, Quebec, and RALEIGH, N.C. — Valeant Pharmaceuticals International Inc. has hiked its offer to buy Salix Pharmaceuticals, Ltd. under an amended agreement. The companies said Monday that Valeant boosted its cash offer to acquire all the outstanding common stock of Salix to $173 per share, or a total deal of about $15.8 billion, from $158
BRIDGEWATER, N.J. — CeraVe Baby baby care products have been awarded the National Eczema Association Seal of Acceptance. Valeant Pharmaceuticals North America said Thursday that the NEA Seal helps consumers make informed purchasing decisions and recognize skin care products that are suitable for eczema or sensitive-skin. CeraVe Baby products include CeraVe Baby Wash & Shampoo, CeraVe
